業績|論文・出版物|

2020

Tolloid-like 1 negatively regulates hepatic differentiation of human iPS cells through transforming growth factor beta signaling

Kiso A., Toba Y., Tsutsumi S., Deguchi S., Igai K., Koshino S., Tanaka Y., Takayama K., Mizuguchi H.
Hepatol. Commun.
4
255-267
2020

Photoactivatable oncolytic adenovirus for optogenetic cancer therapy

Hagihara Y., Sakamoto A., Tokuda T., Yamashita T., Ikemoto S., Kimura A., Haruta M., Sasagawa K., Ohta J., Takayama K., Mizuguchi H.
Cell Death Dis.
11
570
2020

Establishment of MDR1-knockout human induced pluripotent stem cell line

Negoro R., Kawai K., Ichikawa M., Deguchi S., Takayama K., Mizuguchi H.
Drug Metab. Pharmacokinet.
35
288-296
2020

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer

Koujima T., Tazawa H., Ieda T., Araki H., Fushimi T., Shoji R., Kuroda S., Kikuchi S., Yoshida R., Umeda Y., Teraishi F., Urata Y., Mizuguchi H., Fujiwara T.
Mol. Ther. Oncolytics
17
107-117
2020

Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance

Toba Y., Deguchi S., Mimura N., Sakamoto A., Harada K., Hirata K., Takayama K., Mizuguchi H.
PLoS One
15
e0229654
2020

Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody

Kanaya N., Kuroda S., Kakiuchi Y., Kumon K., Tsumura T., Hashimoto M., Morihiro T., Kubota T., Aoyama K., Kikuchi S., Nishizaki M., Kagawa S., Tazawa H., Mizuguchi H., Urata Y., Fujiwara T.
Mol. Ther.
28
794-804
2020

Development of a Novel Oncolytic Adenovirus Expressing a Short-hairpin RNA Against Cullin 4A

Wakabayashi K., Sakurai F., Ono R., Fujiwara T., Mizuguchi H.
Anticancer Res.
40
161-168
2020

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production

Tachibana M., Watanabe N., Koda Y., Oya Y., Kaminuma O., Katayama K., Fan Z., Sakurai F., Kawabata K., Hiroi T., Mizuguchi H.
Int. Immunol.
32
187-201
2020

Generation of human induced pluripotent stem cell-derived hepatocyte-like cells for cellular medicine

Deguchi S., Takayama K., Mizuguchi H.
Biol. Pharm. Bull.
43
608-615
2020

Aspects of gene therapy products using current genome-editing technology in Japan

Yamaguchi T., Uchida E., Okada T., Ozawa K., Onodera M., Kume A., Shimada T., Takahashi S., Tani K., Nasu Y., Mashimo T., Mizuguchi H., Mitani K., Maki K.
Hum. Gene Ther.
31
1043-1053
2020

ヒトiPS細胞由来肝細胞のB型肝炎ウイルス感染評価系への応用

櫻井文教, 水口裕之
ファルマシア
56
1099-1103
2020

薬物動態評価系としてのヒトiPS細胞由来腸管上皮細胞の可能性

山下智起, 横田純平, 乾達也, 水口裕之
Drug Delivery System
35
309-318
2020

CHOPCHOP v3を用いたCRISPR-Cas9の標的配列検索方法

塚本智仁, 酒井英子, 櫻井文教, 水口裕之
Drug Delivery System
35
257-259
2020

 大阪大学大学院 薬学研究科 分子生物学分野 

〒565-0871 大阪府吹田市山田丘1-6 大阪大学 大学院薬学研究科・薬学部 1号館 4階

TEL: 06-6879-8185 FAX: 06-6879-8187

 

Copyright© Laboratory of Biochemistry and Molecular Biology, Graduate School and School of Pharmaceutical Sciences, Osaka University

directed by Prof. Hiroyuki Mizuguchi

  • 分子生物学分野 | 阪大 | 薬学 | 生化 twitter